Market Overview

Oppenheimer Reiterates Perform Rating on Gentiva Health Services on FY2013 Outlook

Related GTIV
US Stock Futures Up Ahead Of McDonald's, Coca-Cola Earnings
Kindred Healthcare Offers Letter to Gentiva's Board

In a report published Wednesday, Oppenheimer analyst Michael Wiederhorn reiterated a Perform rating on Gentiva Health Services (NASDAQ: GTIV).

In the report, Wiederhorn noted, “Gentiva issued its FY2013 outlook, which includes EPS of $0.90-$1.10, compared to our estimate of $1.15 and Street consensus of $1.26. The guidance includes a $0.60 impact from the Medicare sequestration, well above the impact included in our estimate. As a result of the outlook, we are reducing our FY2013-14 estimates to $0.98 and $0.99, from $1.15 and $1.17, respectively.”

Gentiva Health Services closed on Tuesday at $12.62.

Posted-In: OppenheimerAnalyst Color Reiteration Analyst Ratings


Most Popular

Related Articles (GTIV)

Around the Web, We're Loving...

Partner Network

Get Benzinga's News Delivered Free